B. Ardito

Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

M. Ulivelli, G. Marfia, M. Rovaris, 2022, Neurological Sciences.

Natalizumab Treatment in Multiple Sclerosis Patients: A Multicenter Experience in Clinical Practice in Italy

L. Provinciali, C. Gasperini, R. Totaro, 2014, International journal of immunopathology and pharmacology.

Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

M. Ulivelli, G. Marfia, M. Rovaris, 2022, Neurological Sciences.

Safety and Tolerability in Relapsing-Remitting Multiple Sclerosis Patients Treated With High-Dose Subcutaneous Interferon-Beta by Rebiject Autoinjection Over a 1-Year Period: The CoSa Study

C. Pozzilli, C. Gasperini, A. Lugaresi, 2008, Clinical neuropharmacology.

Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

M. Ulivelli, G. Comi, M. Trojano, 2023, Neurological Sciences.